A peptide derived from fibrin(ogen) inhibits angiotensin converting enzyme and potentiates the effects of bradykinin.

No abstract is available for this paper.

• Publication year

  1981

• Venue

  Thrombosis Research

• Publication date

  1981-08-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0049-3848(81)90208-5PMID 6275568
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure-activity relationships of vasoactive peptides derived from fibrin or fibrinogen degraded by plasmin.

  1980cited by this paper
• Angiotensin-converting enzyme: I. New strategies for assay

  1980cited by this paper
• Effects of the converting enzyme inhibitor (SQ 20881) on the pulmonary circulation in man.

  1979cited by this paper
• Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents.

  1977cited by this paper
• The Microembolism Syndrome

  1977cited by this paper
• Assay of kinins by their effects on blood pressure.

  1973cited by this paper
• Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis.

  1971cited by this paper

• PAK: an essential motif for forming beta-turn structures and exhibiting the thrombolytic effect of P6A and its analogs.

  2007cites this paper
• The Usefulness of Angiotensin Converting Enzyme in the Differential Diagnosis of Crohn's Disease and Intestinal Tuberculosis

  2007cites this paper
• Mechanistically Identified Suitable Biomarkers of Exposure, Effect, and Susceptibility for Silicosis and Coal-Worker'S Pneumoconiosis: A Comprehensive Review

  2006cites this paper
• Identification, synthesis and bioassay for the metabolites of P6A.

  2003cites this paper
• Kinin B(1) receptors and the cardiovascular system: regulation of expression and function.

  2000cites this paper
• Kinin B1 receptors and the cardiovascular system: regulation of expression and function

  2000cites this paper
• Kinin B1 receptors as novel anti-inflammatory targets

  2000cites this paper
• Specificity of Pseudomonas aeruginosa serralysin revisited, using biologically active peptides as substrates.

  1998cites this paper
• Serum angiotensin-converting enzyme activity, concentration, and specific activity in granulomatous interstitial lung disease, tuberculosis, and COPD.

  1995cites this paper
• Dynamic changes of fibrinopeptides A and B in sera of burn patients and their effects on vascular endothelial cells.

  1994cites this paper
• Dynamic changes of fibrinopeptides A and B in sera of burn patients and their effects on vascular endothelial cells.

  1994cites this paper
• Replacement of L‐Lys by D‐Lys(NH2) in Peptide Ala‐Arg-Pro‐Ala-Lys (Peptide 6A) Increases Its Coronary Blood Flow‐Promoting Properties

  1994cites this paper
• Design, synthesis, and in vitro activity of bis(succinimido)hexane peptide heterodimers with combined B1 and B2 antagonist activity.

  1994cites this paper
• Plasma fibronectin and angiotensin-converting enzyme: markers of primary pulmonary injury in burn patients.

  1994cites this paper
• Attenuating Effect of Antithrombin III on the Fibrinolytic Activation and Microvascular Derangement in Rat Gastric Mucosa

  1994cites this paper
• Role of platelet activating factor on the fibrinolytic activation in the pathogenesis of gastric mucosal damage induced by endothelin-1.

  1992cites this paper
• Tissue-type plasminogen activator of colonic mucosa in ulcerative colitis. Evidence of endothelium-derived fibrinolytic activation.

  1992cites this paper
• Tissue-type plasminogen activator of colonic mucosa in ulcerative colitis

  1992cites this paper
• Effect of L-arginine and an arginine-containing pentapeptide on canine femoral arterial blood flow.

  1991cites this paper
• Angiotensin converting enzyme inhibitors potentiate the vasorelaxant effect of fibrinogen-derived peptide 6A.

  1991cites this paper
• Angiotensin-converting enzyme: clinical applications and laboratory investigations on serum and other biological fluids.

  1991cites this paper
• Effects of surfactant protein-A on surfactant function in preterm ventilated rabbits.

  1990cites this paper
• Effect of recombinant hirudin, a specific inhibitor of thrombin, on endotoxin-induced intravascular coagulation and acute lung injury in pigs.

  1990cites this paper
• A Reliable Radiometric Assay for the Determination of Angiotensin I-Converting Enzyme Activity in Urine

  1990cites this paper
• Angiotensin converting enzyme inhibitors and expression of des-Arg9-BK (kinin B1) receptors in vivo.

  1989cites this paper
• Effects of Peptide 6A on Coronary Blood Flow Dynamics in Canine Coronary Thrombosis

  1989cites this paper
• Anti-inflammatory drugs modulate histamine release from mast cells induced by fibrinogen degradation products.

  1988cites this paper
• Influence of the fibrin(ogen) degradation product fragment D on the monolayer integrity of cultured vascular endothelial cells. Failure to induce monolayer disorganization.

  1988cites this paper
• Serum angiotensin-converting enzyme: an endothelial cell marker. Application to thromboembolic pathology.

  1988cites this paper
• Effects of low molecular weight fibrin degradation products 6A and 6D on rabbit aorta strips

  1987cites this paper
• Effect of a fibrin-derived vasoactive peptide on pulmonary angiotensin converting enzyme activity and on pressure responses to bradykinin.

  1987cites this paper
• The disposition and metabolism of captopril

  1986cites this paper
• Peptide 6A, a fibrin(ogen) degradation product, increases coronary blood flow.

  1985cites this paper
• SYNTHETIC AND FERMENT ATION -DERIVED ANGIOTENSIN-CONV ERTING ENZYME INHIBITORS

  1985cites this paper
• The Fibrinolytic System in Inflammation

  1985cites this paper
• Synthetic and fermentation-derived angiotensin-converting enzyme inhibitors.

  1985cites this paper
• Angiotensin-converting enzyme inhibitors: biochemical properties and biological actions.

  1984cites this paper
• Angiotensin converting enzyme dependent and non-dependent effects of a fibrinogen-derived pentapeptide on microvascular permeability in rat skin.

  1983cites this paper
• Clotting, microembolism, and inhibition of fibrinolysis in adult respiratory distress.

  1983cites this paper
• Fibrin-derived vasoactive peptides release histamine.

  1983cites this paper
• VASOACTIVE PEPTIDES DERIVED FROM DEGRADATION OF FIBRINOGEN AND FIBRIN

  1983cites this paper
• Pharmacology of kinins: their relevance to tissue injury and inflammation.

  1983cites this paper
• FIBRIN‐DERIVED PEPTIDES AND PULMONARY INJURY

  1982cites this paper
• Metabolic functions of the pulmonary vascular endothelium.

  1982cites this paper
• Pulmonary microembolism as a cause of acute respiratory failure.

  1982cites this paper